Paul Emery (rheumatologist)

Last updated
Professor
Paul Emery
CBE FLSW FRCP FRCPE FMedSci
NationalityUnited Kingdom
Education Cardiff High School [lower-alpha 1] , Churchill College, Cambridge
Occupation(s)Rheumatologist, researcher, academic
Years active1977–present
Medical career
Profession
  • Versus Arthritis Professor of Rheumatology (Leeds), Head of Rheumatology Department (Leeds)
  • 1995-2017 Director (NIHR Leeds Biomedical Research Centre) 2008-2022
  • Head of Academic Unit of Musculoskeletal Disease and Lead Clinician of Rheumatology (Leeds Teaching Hospital Trust) 1994-2017
Institutions
  • Guy’s Hospital/Brompton Hospital (1977-1980)
  • Guy’s/Brighton/Lewisham 1980-1985
  • Walter & Eliza Hall Institute, Australia (1985-1987) [lower-alpha 2]
  • Royal Melbourne Hospital, Australia (1985-1987)
  • University of Birmingham (1988-1995) [lower-alpha 3]
  • University of Leeds (1995-present) [lower-alpha 4]
  • Leeds Teaching Hospital Trust (1997-present) [lower-alpha 5]
Awards
  • Roche Biennial Award for Clinical Rheumatology (1991)
  • Hospital Doctor of the Year Rheumatology (1999)
  • EULAR Prize for outstanding contribution to Rheumatology (2002)
  • NIHR Senior Investigator NMR (2009)
  • Carol Nachman Award for Rheumatology (2012) [lower-alpha 6]
  • The World’s Most Influential Scientific Minds (2015)
  • Highly Cited Researcher in Clinical Medicine (2015) [lower-alpha 7]
  • Highly Cited Researcher (2017) [lower-alpha 8]
  • OBE (2018)
  • Master of the American College of Rheumatology (2018)
  • Meritorious Service Award from EULAR (2020)
  • CBE (2024)
Academic work
Main interestsRheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriatic disease, connective tissue diseases, prevention of autoimmune diseases, factors leading to persistent inflammation, Scleroderma, Sjogren Syndrome, immunopathogenesis, immunotherapy, disease prevention, ultrasound, MRI imaging

Paul Emery CBE FLSW FRCP FRCPE FMedSci is a British rheumatologist, researcher, and academic. Emery has been the Versus Arthritis Professor of Rheumatology at the University of Leeds from 1995 to 2017, [lower-alpha 9] Head of its Rheumatology Department from 1995 to 2008. He is Head of the Academic Unit of Musculoskeletal Disease and Lead Clinician of Rheumatology at the Leeds Teaching Hospital NHS Trust, and was the Director of the NIHR Leeds Biomedical Research Centre from 2009 to 2022. He is known for introducing early intervention in inflammatory arthritis. Emery played a critical role in bringing sensitive imaging (MRI) into rheumatology practice. In 2012, Emery was awarded the Carol Nachman Prize for Rheumatology, [1] and as of 2024, he has published over 1660 peer-reviewed articles with over 160,000 citations. [2] [3] [4] [5] Emery was the most cited European/World Rheumatologist in 2010-2020, and was selected in the European Journal of Clinical Investigation's "list of highly influential biomedical researchers, 1996–2020." [6]

Contents

Early life and education

Emery attended Cardiff High School from 1953 to 1971 (Head Boy) and graduated from Churchill College, Cambridge in 1974. He received his clinical training at Guy's Hospital and at Royal Brompton Hospital was accredited in rheumatology and general internal medicine in 1984. [3]

Career

Emery worked at Guys Hospital from 1977 to 1985 and as House Officer to Senior Registrar and at Royal Brompton Hospital.

In 1985 Emery became Head of Rheumatology at the Walter and Eliza Hall Institute, and a consultant at the Royal Melbourne Hospital.

In 1988 Emery became a Senior Lecturer at the University of Birmingham.

Emery has been the Arthritis Research UK Professor of Rheumatology at the University of Leeds since 1995.

Emery was inaugural President of the International extremity MRI society (ISEMIR). [4]

Emery has been a senior investigator at the National Institute for Health and Care Research since 2008. [4]

From 2009 to 2011 Emery was President of the European Alliance of Associations for Rheumatology (EULAR).

In 2010 he ranked first as the most cited European Rheumatologist with 16,952 citations, according to Lab Times. [7] [8]

In 2013 Boyack et al. published "A list of highly influential biomedical researchers, 1996–2011." in the European Journal of Clinical Investigation. They selected Emery among 532 authors who belonged to the 400 researchers with highest total citation count (25,142 or more citations). As of the time of publishing the list, Emery had 657 papers published with 30,096 citations. [6]

Emery was inaugural chair of FOREUM Executive, the European Foundation for Research in Rheumatology, from 2013 to 2019. [9] Emery is currently a member of the Board of Trustees.

In 2015, Emery was elected a Fellow of the Academy of Medical Sciences. [10]

In 2017 Emery ranked first as the most cited European Rheumatologist with 20,223 citations, according to Lab Times. [11] Emery was ranked among the world’s top 0.1% of Rheumatoid Arthritis experts by Expertscape in 2020. [12] [13]

Emery was appointed Officer of the Order of the British Empire (OBE) in 2018 by the Queen and Commander of the Order of the British Empire (CBE) in the 2024 New Year Honours [14] [15] [16] [17] by the King for services to rheumatology. [18]

In 2021 Emery became a Fellow of the Learned Society of Wales (FLSW). [19]

Bibliography

Books

Select publications

Related Research Articles

<span class="mw-page-title-main">Arthritis</span> Type of joint disorder

Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include joint pain and stiffness. Other symptoms may include redness, warmth, swelling, and decreased range of motion of the affected joints. In some types of arthritis, other organs are also affected. Onset can be gradual or sudden.

<span class="mw-page-title-main">Rheumatoid arthritis</span> Type of autoimmune arthritis

Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. It typically results in warm, swollen, and painful joints. Pain and stiffness often worsen following rest. Most commonly, the wrist and hands are involved, with the same joints typically involved on both sides of the body. The disease may also affect other parts of the body, including skin, eyes, lungs, heart, nerves, and blood. This may result in a low red blood cell count, inflammation around the lungs, and inflammation around the heart. Fever and low energy may also be present. Often, symptoms come on gradually over weeks to months.

Rheumatology is a branch of medicine devoted to the diagnosis and management of disorders whose common feature is inflammation in the bones, muscles, joints, and internal organs. Rheumatology covers more than 100 different complex diseases, collectively known as rheumatic diseases, which includes many forms of arthritis as well as lupus and Sjögren's syndrome. Doctors who have undergone formal training in rheumatology are called rheumatologists.

<span class="mw-page-title-main">Etoricoxib</span> COX-2 selective NSAID medication

Etoricoxib, sold under the brand name Arcoxia, is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data.

<span class="mw-page-title-main">Synovitis</span> Medical condition

Synovitis is the medical term for inflammation of the synovial membrane. This membrane lines joints that possess cavities, known as synovial joints. The condition is usually painful, particularly when the joint is moved. The joint usually swells due to synovial fluid collection.

Palindromic rheumatism (PR) is a syndrome characterised by recurrent, self-resolving inflammatory attacks in and around the joints, and consists of arthritis or periarticular soft tissue inflammation. The course is often acute onset, with sudden and rapidly developing attacks or flares. There is pain, redness, swelling, and disability of one or multiple joints. The interval between recurrent palindromic attacks and the length of an attack is extremely variable from few hours to days. Attacks may become more frequent with time but there is no joint damage after attacks. It is thought to be an autoimmune disease, possibly an abortive form of rheumatoid arthritis.

Sir Marc Feldmann,, is an Australian-educated British immunologist. He is a professor at the University of Oxford and a senior research fellow at Somerville College, Oxford.

<span class="mw-page-title-main">Enteropathic arthropathy</span> Medical condition

Enteropathic arthropathy commonly referred to as enteropathic arthritis, is a type of arthritis linked to Crohn's disease, ulcerative colitis, and chronic inflammatory bowel diseases.

<span class="mw-page-title-main">Antisynthetase syndrome</span> Medical condition

Antisynthetase syndrome (ASS) is a multisystematic autoimmune disease associated with inflammatory myositis, interstitial lung disease, and antibodies directed against various synthetases of aminoacyl-transfer RNA. Other common symptoms include mechanic's hands, Raynaud's phenomenon, arthritis, and fever.

The Rheumatoid Arthritis Quality of Life Questionnaire (RAQoL) is a disease-specific patient-reported outcome measure which determines the effect rheumatoid arthritis has on a patient's quality of life. The RAQoL has 30 items with a yes and no response format and takes about six minutes to complete.

Claus Manniche is a Danish rheumatologist, Consultant and Professor. His main research interests are clinical databases in back pain and research methodology. He has authored more than 120 journal articles and co-authored several books.

Patient satisfaction is a measure of the extent to which a patient is content with the health care which they received from their health care provider.

Paul-Peter Tak M.D. PhD FMedSci is an immunologist and academic specialising in the fields of internal medicine, rheumatology and immunology. Tak has been the President & CEO of Candel Therapeutics since September 2020.

Eric John Holborow was a British physician, rheumatologist, and immunologist, known for his pioneering research on autoimmunity.

<span class="mw-page-title-main">Lars Klareskog</span> Biologist

Lars Klareskog is a Swedish physician, immunologist, and rheumatologist, known for research into the genetics of autoimmune diseases such as rheumatoid arthritis (RA).

<span class="mw-page-title-main">Rachelle Buchbinder</span> Australian rheumatologist and medical researcher

Rachelle Buchbinder is an Australian rheumatologist and clinical epidemiologist. Her clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal conditions. She promotes improvement of communication with patients and health literacy in the community.

<span class="mw-page-title-main">Soumya Raychaudhuri</span> Medical researcher (born 1975)

Soumya Raychaudhuri is a professor of medicine and biomedical informatics at Harvard Medical School, and an Institute Member at Broad Institute. He is the JS Coblyn and MB Brenner Distinguished Chair in Rheumatology/Immunology and a practicing rheumatologist at Brigham and Women's Hospital. He is the director for the Center for Data Sciences at Brigham and Harvard. His research focuses on human genetics and computational genomics to understand immune-mediated diseases.

Fiona Marion Florence McQueen is a New Zealand rheumatologist, environmentalist and children's writer, and was a full professor at the University of Auckland before retiring to run a private herbalist practice in Glenorchy in Otago. She was New Zealand's first woman professor of rheumatology.

<span class="mw-page-title-main">Josef Smolen</span> Austrian Rheumatologist

Josef Smolen is an Austrian rheumatologist and immunologist and professor emeritus at the Medical University of Vienna. Since 2018 he is chairman emeritus of the Department of Internal Medicine 3 and the Division of Rheumatology at the Medical University of Vienna and Vienna General Hospital and was the chairman of the 2nd Medical Department and Center for Diagnosis and Therapy of Rheumatic Diseases at the Lainz Hospital, now the Hietzing Clinic of the Vienna Health Association from 1989 to 2017.

Rebecca Grainger is a New Zealand academic rheumatologist, and is a full professor at the University of Otago, specialising in rheumatoid arthritis and osteoarthritis, and gout. She is also interested in the use of technology for medical education and digital health.

References

  1. ↑ Quinn, Richard (2012-08-08). "Educational Leader Honored with Top Rheumatology Award".
  2. ↑ "Rheumatoid arthritis and switching TNFis: an interview with Professor Paul Emery, University of Leeds". News-Medical.net. 2014-03-12. Retrieved 2023-10-07.
  3. 1 2 "Paul Emery". The Lancet . 358 (9280). 11 August 2001. doi:10.1016/S0140-6736(01)05618-5.
  4. 1 2 3 "Paul Emery". rheumatology.medicinematters.com. Retrieved 2023-10-07.
  5. ↑ "Professor Paul Emery OBE FLSW MA MD FRCP FRCPE FMedSci MACR". Leeds Biomedical Research Centre. Retrieved 2023-10-07.
  6. 1 2 Boyack, Kevin W.; Klavans, Richard; Sorensen, Aaron A.; Ioannidis, John P.A. (December 2013). "A list of highly influential biomedical researchers, 1996–2011". European Journal of Clinical Investigation. 43 (12): 1339–1365. doi: 10.1111/eci.12171 . ISSN   0014-2972.
  7. ↑ "Publication Analysis 1997–2008: Rheumatology" (PDF). Lab Times. p. 52. Archived from the original (PDF) on 11 July 2017.
  8. ↑ Gardner, Joshua (2011-03-17). "Prof Emery most highly cited European rheumatologist". Leeds Biomedical Research Centre. Retrieved 2023-10-07.
  9. ↑ https://www.youtube.com/watch?v=-pzxyWMs7tc
  10. ↑ "Professor Paul Emery | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 2023-10-25.
  11. ↑ Gransalke, Kathleen. "Rheumatology Publication Analysis 2007-2013". Lab Times. Archived from the original on 16 October 2017. The most-cited papers in rheumatology research, mentioned earlier, already give us a clue about our highly-cited rheumatologists' favourite research subject. That's right: rheumatoid arthritis. Not less than 24 of our top 30 researchers work exclusively or primarily on this disease. The ranking's number one, Paul Emery, is no exception. In his research, he wants to elucidate RA's immunopathogenesis and immunotherapy. In addition, he studies spondyloarthritis, another rheumatoid inflammatory disease, which can cause the fusion of spinal vertebrae, leading to stiffness and inflexibility.
  12. ↑ "Expertise in Arthritis, Rheumatoid May 2020".
  13. ↑ Index, AD Scientific. "Paul Emery - AD Scientific Index 2024". www.adscientificindex.com. Retrieved 2024-05-09.
  14. ↑ "Colleagues celebrate New Year Honours". forstaff.leeds.ac.uk. Retrieved 2024-01-06.
  15. ↑ "Dr Benjamin Ellis and Professor Paul Emery named in the 2024 New Years Honours list". Versus Arthritis. Retrieved 2024-01-06.
  16. ↑ "King's New Year Honours for RCP fellows". RCP London. 2024-01-04. Retrieved 2024-01-06.
  17. ↑ "Fellows recognised in New Year Honours 2024". acmedsci.ac.uk. Retrieved 2024-01-06.
  18. ↑ "No. 64269". The London Gazette (Supplement). 30 December 2023. p. N9.
  19. ↑ Wales, The Learned Society of. "Paul Emery". The Learned Society of Wales. Retrieved 2023-10-07.

Notes

  1. ↑ He was a Head boy at Cardiff High School
  2. ↑ Head of Rheumatology Unit
  3. ↑ Senior Lecturer Rheumatology
  4. ↑ Arthritis Research UK Professor of Rheumatology
  5. ↑ Lead Clinician Rheumatology (1997-2005), Clinical Director Rheumatology (2000- 2018), Director of the Leeds Musculoskeletal Biomedical Research Centre 2008-2022
  6. ↑ "In honour of his outstanding innovative research work in the field of rheumatology"
  7. ↑ Under Clinical Medicine. Highly Cited Researcher according to Thompson Reuters.
  8. ↑ According to Web of Science
  9. ↑ formerly "Arthritis Research Campaign Professor"
  10. ↑ And a further 89 books.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.